4.7 Article

Prognostic Value of Fractional Flow Reserve Linking Physiologic Severity to Clinical Outcomes

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 64, 期 16, 页码 1641-1654

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2014.07.973

关键词

fractional flow reserve; meta-analysis; prognosis; threshold

资金

  1. Weatherhead PET Center for Preventing and Reversing Atherosclerosis
  2. St. Jude Medical
  3. Terumo
  4. Biosensors
  5. Abbott Vascular, Terumo
  6. Medtronic
  7. Fondation Vaudoise de Cardiologie, Lausanne, Switzerland
  8. Volcano
  9. Grants-in-Aid for Scientific Research [24591100] Funding Source: KAKEN

向作者/读者索取更多资源

BACKGROUND Fractional flow reserve (FFR) has become an established tool for guiding treatment, but its graded relationship to clinical outcomes as modulated by medical therapy versus revascularization remains unclear. OBJECTIVES The study hypothesized that FFR displays a continuous relationship between its numeric value and prognosis, such that lower FFR values confer a higher risk and therefore receive larger absolute benefits from revascularization. METHODS Meta-analysis of study- and patient-level data investigated prognosis after FFR measurement. An interaction term between FFR and revascularization status allowed for an outcomes-based threshold. RESULTS A total of 9,173 (study-level) and 6,961 (patient-level) lesions were included with a median follow-up of 16 and 14 months, respectively. Clinical events increased as FFR decreased, and revascularization showed larger net benefit for lower baseline FFR values. Outcomes-derived FFR thresholds generally occurred around the range 0.75 to 0.80, although limited due to confounding by indication. FFR measured immediately after stenting also showed an inverse relationship with prognosis (hazard ratio: 0.86, 95% confidence interval: 0.80 to 0.93; p < 0.001). An FFR-assisted strategy led to revascularization roughly half as often as an anatomy-based strategy, but with 20% fewer adverse events and 10% better angina relief. CONCLUSIONS FFR demonstrates a continuous and independent relationship with subsequent outcomes, modulated by medical therapy versus revascularization. Lesions with lower FFR values receive larger absolute benefits from revascularization. Measurement of FFR immediately after stenting also shows an inverse gradient of risk, likely from residual diffuse disease. An FFR-guided revascularization strategy significantly reduces events and increases freedom from angina with fewer procedures than an anatomy-based strategy. (C) 2014 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据